Yanyan Zhang

138 Hanzhong Road
Nanjing, 210029, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Body mass index modifies cardiovascular risk trajectory: a Chinese longitudinal cohort study.

Body mass index modifies cardiovascular risk trajectory: a Chinese longitudinal cohort study.

Journal: BMC public health

Published: November 28, 2025

Chinese Population-Wide Lipid Trajectories From Age 20 to 85 Years: Sex- and Adiposity-Specific Patterns.

Chinese Population-Wide Lipid Trajectories From Age 20 to 85 Years: Sex- and Adiposity-Specific Patterns.

Journal: JACC. Asia

Published: June 09, 2025

Triglyceride-glucose index trajectories and the incident risk of type 2 diabetes mellitus in Chinese adults with normal weight: the China-PAR project.

Triglyceride-glucose index trajectories and the incident risk of type 2 diabetes mellitus in Chinese adults with normal weight: the China-PAR project.

Journal: International journal of obesity (2005)

Published: April 11, 2025

Unstable resting heart rate trajectory patterns are associated with an increase in incident risk of type 2 diabetes mellitus: the China-PAR project.

Unstable resting heart rate trajectory patterns are associated with an increase in incident risk of type 2 diabetes mellitus: the China-PAR project.

Journal: Journal of epidemiology and community health

Published: November 25, 2024

Insight into prostate cancer osteolytic metastasis by RelB coordination of IL-8 and S100A4.

Insight into prostate cancer osteolytic metastasis by RelB coordination of IL-8 and S100A4.

Journal: Clinical and translational medicine

Published: May 18, 2024

Associations of body mass index trajectory, waist circumference trajectory, or both with type 2 diabetes mellitus risk in Chinese adults: The China-PAR project.

Associations of body mass index trajectory, waist circumference trajectory, or both with type 2 diabetes mellitus risk in Chinese adults: The China-PAR project.

Journal: Diabetes, obesity & metabolism

Published: November 20, 2023

RelB-activated GPX4 inhibits ferroptosis and confers tamoxifen resistance in breast cancer.

RelB-activated GPX4 inhibits ferroptosis and confers tamoxifen resistance in breast cancer.

Journal: Redox biology

Published: June 25, 2023

HNRNPC suppresses tumor immune microenvironment by activating Treg cells promoting the progression of prostate cancer.

HNRNPC suppresses tumor immune microenvironment by activating Treg cells promoting the progression of prostate cancer.

Journal: Cancer science

Published: November 01, 2022

RelB upregulates PD-L1 and exacerbates prostate cancer immune evasion.

RelB upregulates PD-L1 and exacerbates prostate cancer immune evasion.

Journal: Journal of experimental & clinical cancer research : CR

Published: September 02, 2021

RelB sustains endocrine resistant malignancy: an insight of noncanonical NF-κB pathway into breast Cancer progression.

RelB sustains endocrine resistant malignancy: an insight of noncanonical NF-κB pathway into breast Cancer progression.

Journal: Cell communication and signaling : CCS

Published: October 15, 2019

Endocrinotherapy resistance of prostate and breast cancer: Importance of the NF‑κB pathway (Review).

Endocrinotherapy resistance of prostate and breast cancer: Importance of the NF‑κB pathway (Review).

Journal: International journal of oncology

Published: October 07, 2019

MicroRNA-16 sensitizes drug-resistant breast cancer cells to Adriamycin by targeting Wip1 and Bcl-2.

MicroRNA-16 sensitizes drug-resistant breast cancer cells to Adriamycin by targeting Wip1 and Bcl-2.

Journal: Oncology letters

Published: November 09, 2018

Showing 1-12 of 14

Last Updated: 09/26/2026